The AEGEA Vapor System is the first endometrial ablation system specifically designed to be used in the doctor’s office.

Adaptive Vapor Ablation

The AEGEA Vapor System uses Adaptive Vapor Ablation, an innovative solution for endometrial ablation that effectively and safely treats menorrhagia.

After nearly a decade of research and development, a new approach to treat menorrhagia has arrived. By harnessing the ability of natural water vapor to efficiently conform to the unique differences of a woman’s anatomy, AEGEA provides a treatment option for menorrhagia.

The AEGEA Vapor System is the first FDA-approved endometrial ablation system specifically designed for the doctor’s office and delivers lasting results and new possibilities for physicians and patients. The AEGEA Vapor System is designed to be safe, effective, simple, and adaptable to different patient anatomies.

Safe

Only FDA-approved,device with patented Smart SealTM and Integrity ProTM technology

Vapor Probe Insertion
  • slender, soft, flexible tip
  • cervical collar aids in placing the Vapor Probe just beyond the internal cervical os
  • no requirement to touch the uterine fundus
  • cervical dilation not required
SmartSealTM
  • provides automated real-time monitoring with active management of uterine and cervical seal
  • monitors balloon pressure, uterine pressure and cervical temperature and is designed to confine vapor to the uterine cavity during treatment
IntegrityProTM
  • includes new patented secondary safety check above and beyond the integrity test to provide an added level of confidence
  • Uterine Cavity Integrity Test uniquely includes confirmation of correct placement of the device
  • vapor will not be initiated until the safety checks are successfully completed

Effective

Effectiveness supported by significant bleeding reduction, improved quality of life and high patient satisfaction. One year after the treatment in the Pivotal study, the following results were seen:

  • 79% of women experienced significant reduction in their menstrual bleedinga
  • 90% had bleeding reduced by ≥50%
  • 99% experienced an improvement in quality of life
  • 93% would recommend the procedure to a friend
  • 91% were satisfied or very satisfied

Simple

Fully automated safety and delivery system provides peace of mind for in-office procedure.

  • a 4-minute procedure, which includes 2 minutes of vapor treatment, can be performed in-office without need for general anesthesia no arrays to deploy, no treatment balloons to inflate, no ice-balls to form
  • no intracavitary manipulation and no dilation required
  • universal treatment parameters obviate need for generator programming
  • no concurrent ultrasound required

Adaptable

Conforms to uterine cavities with unique differences.

  • uterine cavities up to 12 cm in length
  • any uterine width
  • uterine cavities with certain types of fibroids
  • patients with a prior low transverse cesarean section
  • in the presence of Essure®
REFERENCES
a Levie MD, Chudnoff SG. A Prospective, Multicenter, Pivotal Trial to Evaluate the Safety and Effectiveness of the AEGEA Vapor Endometrial Ablation System. J Minim Invas Gynecol 2018 Jul in press article.
Treat. Relieve. Restore. Discover what’s possible.